SCHEMBL2574473

SCHEMBL2574473

O[Si](c1ccccc1F)(c1ccccc1F)c1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.40
CES1 P23141 3/20 0.40
ACHE P22303 1/20 0.39
NFE2L2 Q16236 1/20 0.38
ALDH1A1 P00352 1/20 0.37
ALOX15 P16050 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DCUN1D1 Q96GG9 1/20 0.34
PDK2 Q15119 2/20 0.33
KCNN4 O15554 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
BCHE P06276 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18692020 0.81 ACHE (0.46) CES2CES1ACHENFE2L2ALDH1A1
SCHEMBL2568052 0.81 CES2 (0.43) CES2CES1PDK2MEN1KMT2A
SCHEMBL3792566 0.74 ACHE (0.38) CES2CES1ACHENFE2L2ALDH1A1
SCHEMBL8932025 0.74 ACHE (0.43) CES2CES1ACHENFE2L2NPC1
Boric Acid SCHEMBL29277889 0.72 ACHE (0.37) CES2CES1ACHENFE2L2ALDH1A1
SCHEMBL28217811 0.72 ACHE (0.42) CES2CES1ACHENFE2L2NPC1
SCHEMBL15091550 0.72 ACHE (0.42) CES2CES1ACHENFE2L2ALDH1A1
SCHEMBL29214133 0.71 CES2 (0.41) CES2CES1ACHEALDH1A1ALOX15
Bromide SCHEMBL19405493 0.70 ACHE (0.35) CES2CES1ACHENFE2L2ALDH1A1
Hydrochloric Acid SCHEMBL19405604 0.70 ACHE (0.35) CES2CES1ACHENFE2L2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10620481-B2 Optical alignment film composition, optical alignment film, optical laminate, and image display device FUJIFILM CORPORATION (JP) 2020-04-14 US disclosed
US-20180246381-A1 OPTICAL ALIGNMENT FILM COMPOSITION, OPTICAL ALIGNMENT FILM, OPTICAL LAMINATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2018-08-30 US disclosed
US-8993470-B2 Catalysts for the alkyne metathesis STUDIENGESELLSCHAFT KOHLE MBH (DE) 2015-03-31 US disclosed
EP-2556078-B1 CATALYSTS FOR ALKYNE METATHESIS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2014-09-24 EP disclosed
US-20130144102-A1 CATALYSTS FOR THE ALKYNE METATHESIS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2013-06-06 US disclosed
EP-2556078-A1 CATALYSTS FOR ALKYNE METATHESIS Studiengesellschaft Kohle MbH (DE) 2013-02-13 EP disclosed
WO-2011120508-A1 CATALYSTS FOR ALKYNE METATHESIS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2011-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130144102-A1 CATALYSTS FOR THE ALKYNE METATHESIS MSH6, AP3M1, PMS2 CES2 2740/4885CES1 4172/4885ACHE 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.